FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/096662 [Registered on: 30/10/2025] Trial Registered Prospectively
Last Modified On: 27/10/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Case Control Study 
Study Design  Single Arm Study 
Public Title of Study   Clinical, Anthropometric and Hormonal Study in Patients Of Female Pattern Hair Loss. 
Scientific Title of Study   A Study of Clinical, Anthropometric and Hormonal association in Patients Of Female Pattern Hair Loss and healthy controls. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Niki Patel  
Designation  1st year PG Resident 
Affiliation  GCS Medical College Hospital and Research Centre 
Address  OPD 35,Ground floor,GCS Medical College Hospital and Research Centre Opp DRM Office Near Chamunda Bridge Naroda Road Ahmedabad Ahmadabad GUJARAT 380025 India Ahmadabad GUJARAT 380025 India

Ahmadabad
GUJARAT
38025
India 
Phone  9426897360  
Fax    
Email  patelniki311@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Nayan H Patel 
Designation  Professor and HOD 
Affiliation  GCS Medical College Hospital and Research Centre 
Address  OPD 35, ground floor,GCS Medical College Hospital and Research Centre,Opp DRM Office Near Chamunda Bridge Naroda Road Ahmedabad Ahmadabad GUJARAT 380025 India Ahmadabad GUJARAT 380025 India

Ahmadabad
GUJARAT
380025
India 
Phone  9925011309  
Fax    
Email  nayan.patel@gcsmc.org  
 
Details of Contact Person
Public Query
 
Name  Dr Nayan H Patel 
Designation  Professor and HOD 
Affiliation  GCS Medical College Hospital and Research Centre 
Address  OPD 35, ground floor,GCS Medical College Hospital and Research Centre,Opp DRM Office Near Chamunda Bridge Naroda Road Ahmedabad Ahmadabad GUJARAT 380025 India Ahmadabad GUJARAT 380025 India

Ahmadabad
GUJARAT
380025
India 
Phone  9925011309  
Fax    
Email  nayan.patel@gcsmc.org  
 
Source of Monetary or Material Support  
GCS hospital Opp. D.R.M. Office, Naroda Rd, nr. Chamunda Bridge, Ahmedabad, Gujarat 380025 Ahmadabad GUJARAT 380025 India  
 
Primary Sponsor  
Name  NIL 
Address  NIL 
Type of Sponsor  Other [] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Patel Niki  GCS Medical College Hospital & Research Centre  Department of dermatology GCS Medical College Hospital and Research Centre Opp DRM Office Near Chamunda Bridge Naroda Road Ahmedabad Ahmadabad GUJARAT Ahmadabad GUJARAT
Ahmadabad
GUJARAT 
9426897360

patelniki311@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee GCS medical college,hospital and reasearch centre(IECGCSMCHRC)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L649||Androgenic alopecia, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  12.00 Year(s)
Age To  46.00 Year(s)
Gender  Female 
Details  Case:

1.Female patients with clinical and trichoscopic diagnosis of FPHL.
2.Age between 12-46 year
Control:
1.Age-matched healthy females without hair loss.
2.No known dermatological or systemic conditions affecting hair.
 
 
ExclusionCriteria 
Details  1.Any pre-existing endocrine disorder like diabetes mellites and thyroid disorder
2.Any known genetic condition effecting the hair
3.Associated Auto immune condition affecting hair like alopecia areata, systemic lupus erythematous
4.Patients on hormonal therapy, hair treatments, or medications affecting hair growth or taking OC Pills in last 2 years
5.Pregnant and lactating females
6.History of abortion in last six months
7.History of any major medical or surgical illness in last six months 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1.To determine difference of clinical parameters in subjects with and without FPHL
2.To determine difference of anthropometric parament in subjects with and without FPHL
3.To determine difference of hormonal profile in subjects with and without FPH 
day 0 
 
Secondary Outcome  
Outcome  TimePoints 
1.To determine the corelation of clinical features & anthropometric parameters in patient of FPHL
2.To determine corelation of the urinary metabolites of androgen metabolism like androstenediol & Androsterone with clinical features in patient of FPH 
day 0 
 
Target Sample Size   Total Sample Size="78"
Sample Size from India="78" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   22/11/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Female Pattern Hair Loss (FPHL), also known as androgenetic alopecia, is a progressive, non-scarring alopecia that primarily affects women, leading to significant psychological distress and diminished quality of life. The prevalence of FPHL is increasing in India, yet comprehensive epidemiological and clinical studies remain limited. The pathophysiology of FPHL is multifactorial, involving genetic predisposition, hormonal imbalances, and environmental factors Female Pattern Hair Loss (FPHL) is a common non-scarring alopecia characterized by progressive thinning of hair over the central and frontal scalp regions, most commonly observed in women after puberty. Although often considered a cosmetic issue, emerging evidence suggests that FPHL may be associated with underlying hormonal and metabolic disturbances, including hyperandrogenism, insulin resistance, and features of metabolic syndrome. The present study, titled “Clinical, Anthropometric and Hormonal Study in Patients of Female Pattern Hair Loss,” is designed as a hospital-based, epidemiological, observational, analytic, case control study to investigate and compare the clinical profile, anthropometric measurements, and hormonal parameters in women with FPHL and age-matched healthy controls. The study population includes 76 female patients aged 12 to 46 years clinically diagnosed with FPHL based on the Ludwig classification, along with age-matched controls without clinical signs of hair loss. A comprehensive clinical assessment, trichoscopic examination, and anthropometric evaluation including body mass index (BMI), waist-hip ratio, mid-arm circumference, and body composition analysis will be conducted. In addition, blood samples will be collected to measure hormonal parameters such as serum total and free testosterone, DHEAS, LH, FSH, and prolactin. The primary objective is to determine differences in hormonal and anthropometric profiles between cases and controls, with a view to identifying potential markers that may correlate with disease severity. The sample size was calculated using standard statistical formulas for comparing means, and was based on published reference values for DHEAS and BMI , resulting in an estimated requirement of 38 participants per group to ensure adequate power for both primary outcomes. Statistical analysis will involve appropriate parametric or non-parametric tests to assess the significance of observed differences. This study is expected to contribute to the understanding of FPHL as a multifactorial disorder with systemic implications and may offer insights into early diagnosis, risk stratification, and individualized management strategies.  
Close